Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Cash Flows

 v2.3.0.11
Consolidated Statement of Cash Flows (USD $)
In Thousands
 12 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2009
Net income (loss) $ 794,488 $ 212,300 $ (523,368)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization 86,044 87,348 135,848
Asset impairment charges 10,568 15,149 452,620
Net gain on sale of real estate assets (1,372) (2,984) (4,071)
Non-cash stock-based compensation expense 81,430 85,982 105,535
Provision for doubtful accounts 0 (2,888) 23,279
Net loss (gain) on sale of marketable securities and other investments (2,479) (5,077) 635
Deferred income taxes 64,736 (19,865) 59,697
Tax charge from equity awards 0 (5,133) (17,880)
Excess tax benefit from equity awards (71) 0 (1,691)
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business combinations:      
Decrease (increase) in accounts receivable, net (128,219) (220,857) 277,331
Decrease (increase) in inventories (170,141) (27,715) 120,249
Decrease (increase) in other assets (56,743) 102,033 17,729
Increase (decrease) in accounts payable 34,259 44,381 (46,796)
Increase (decrease) in deferred system profit (12,425) 108,943 (54,978)
Increase (decrease) in other liabilities 123,091 76,183 (348,455)
Net cash provided by operating activities 823,166 447,800 195,684
Cash flows from investing activities:      
Acquisitions of businesses, net of cash received 0 (1,500) (141,399)
Capital expenditures, net (51,151) (30,202) (22,226)
Proceeds from sale of assets 18,185 5,878 21,814
Purchase of available-for-sale securities (1,142,491) (1,080,412) (1,008,905)
Proceeds from sale and maturity of available-for-sale securities 795,762 854,970 653,291
Purchase of trading securities (63,005) (77,295) (67,240)
Proceeds from sale of trading securities 83,190 100,597 79,765
Net cash provided used in investing activities (359,510) (227,964) (484,900)
Cash flows from financing activities:      
Issuance of common stock 124,573 35,867 40,108
Tax withholding payments related to vested and released restricted stock units (22,557) (13,514) (12,252)
Payment of dividends to stockholders (167,398) (102,409) (102,149)
Excess tax benefit from equity awards 71 0 1,691
Common stock repurchases (234,844) (136,275) (226,515)
Net cash used in financing activities (300,155) (216,331) (299,117)
Effect of exchange rate changes on cash and cash equivalents 17,910 1,446 (14,806)
Net increase (decrease) in cash and cash equivalents 181,411 4,951 (603,139)
Cash and cash equivalents at beginning of period 529,918 524,967 1,128,106
Cash and cash equivalents at end of period 711,329 529,918 524,967
Supplemental cash flow disclosures:      
Income taxes paid (refund received), net 262,086 (13,989) (23,144)
Interest paid $ 52,819 $ 52,438 $ 56,021